VENZUKITAGENE AUTOLEUCEL EXPRESSED ANTI-IL-13R.ALPHA.2 CHIMERIC ANTIGEN RECEPTOR
UNII CP7TR28WYW

Substance Identification & Data

This profile provides standardized clinical and technical data for Venzukitagene Autoleucel Expressed Anti-il-13r.alpha.2 Chimeric Antigen Receptor, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CP7TR28WYW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CP7TR28WYW

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VENZUKITAGENE AUTOLEUCEL EXPRESSED ANTI-IL-13R.ALPHA.2 CHIMERIC ANTIGEN RECEPTOR

Official standardized name for this substance within the FDA UNII nomenclature system.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Venzukitagene Autoleucel Expressed Anti-il-13r.alpha.2 Chimeric Antigen Receptor. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

VENZUKITAGENE AUTOLEUCEL EXPRESSED ANTI-IL-13R.ALPHA.2 CHIMERIC ANTIGEN RECEPTOR

External Clinical & Regulatory Resources